A detailed history of Simplify Asset Management Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 245,487 shares of AKRO stock, worth $7.79 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
245,487
Previous 245,676 0.08%
Holding current value
$7.79 Million
Previous $6.21 Million 7.19%
% of portfolio
0.43%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$18.31 - $24.62 $3,460 - $4,653
-189 Reduced 0.08%
245,487 $5.76 Million
Q1 2024

May 13, 2024

BUY
$17.76 - $31.18 $3.3 Million - $5.8 Million
185,899 Added 310.99%
245,676 $6.21 Million
Q1 2023

May 10, 2023

BUY
$37.27 - $50.24 $2.23 Million - $3 Million
59,777 New
59,777 $2.29 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.47B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.